Lanreotide
Somatuline Depot · Lanreotide acetate
A long-acting somatostatin analog approved for acromegaly and for certain neuroendocrine tumours. Its extended-release formulation gives it one of the longest dosing intervals of any peptide in this library.
Tracking and educational reference only, on values you enter yourself. Not medical advice or a dosing recommendation.
Half-life
~23-30 days, extended-release subcutaneous. Half-life is an educational pharmacology figure, drawn from public sources, and is not a schedule or dosing instruction.
Storage & handling
Supplied in a prefilled syringe; refrigerated and protected from light per its label.
References
- FDA label: lanreotide acetate injection (NDA 215395)
Read the source
Related in Growth Hormone
Educational reference only, compiled from public sources. Not medical advice, diagnosis, treatment, or a dosing recommendation, and not a recommendation to use any compound. Many compounds listed are research materials not approved for human use. Consult a qualified professional.